SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The revenue zoomed 13.49% to Rs. 1663.22 millions for the quarter ended December 2025 as compared to Rs. 1465.52 millions during the corresponding quarter last year.Good  Net Profit growth of 37.70% reported above the corresponding previous quarter figure of Rs. 207.70 millions to Rs. 286.01 millioins.Operating profit surged to 387.42 millions from the corresponding previous quarter of 326.34 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202503 202403 % Var
Sales 1663.22 1465.52 13.49 4837.53 4550.48 6.31 6232.30 5805.50 7.35
Other Income 151.46 89.70 68.85 376.50 293.57 28.25 224.77 344.22 -34.70
PBIDT 387.42 326.34 18.72 1104.78 1041.32 6.09 1239.71 1343.30 -7.71
Interest 2.98 7.28 -59.07 7.39 15.16 -51.25 18.83 14.63 28.71
PBDT 384.44 319.06 20.49 1097.39 1026.16 6.94 1220.88 1328.67 -8.11
Depreciation 37.21 32.24 15.42 108.17 96.72 11.84 128.99 106.25 21.40
PBT 347.23 286.82 21.06 989.22 929.44 6.43 1091.89 1222.42 -10.68
TAX 61.22 79.12 -22.62 226.62 221.71 2.21 268.42 289.38 -7.24
Deferred Tax 1.12 -1.33 -184.21 35.78 34.95 2.37 15.15 34.95 -56.65
PAT 286.01 207.70 37.70 762.60 707.73 7.75 823.47 933.04 -11.74
Equity 200.30 200.30 0.00 200.30 200.30 0.00 200.30 200.30 0.00
PBIDTM(%) 23.29 22.27 4.61 22.84 22.88 -0.20 19.89 23.14 -14.03

Lincoln Pharma Share Price

645.40 -28.20 (-4.19%)
30-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.20
Dr. Reddys Lab 1322.95
Cipla 1309.90
Zydus Lifesciences 891.65
Lupin 2303.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×